OUR STORE IS CLOSED ON ANZAC DAY: THURSDAY 25 APRIL

Close Notification

Your cart does not contain any items

$350.95

Paperback

Not in-store but you can order this
How long will it take?

QTY:

English
Academic Press Inc
13 August 2020
Lipid Signaling and Metabolism provides foundational knowledge and methods to examine lipid metabolism and bioactive lipid signaling mediators that regulate a broad spectrum of biological processes and disease states. Here, world-renowned investigators offer a basic examination of general lipid, metabolism, intracellular lipid storage and utilization that is followed by an in-depth discussion of lipid signaling and metabolism across disease areas, including obesity, diabetes, fatty liver disease, inflammation, cancer, cardiovascular disease and mood-related disorders. Throughout, authors demonstrate how expanding our understanding of lipid mediators in metabolism and signaling enables opportunities for novel therapeutics.

Emphasis is placed on bioactive lipid metabolism and research that has been impacted by new technologies and their new potential to transform precision medicine.

Edited by:  
Imprint:   Academic Press Inc
Country of Publication:   United States
Dimensions:   Height: 234mm,  Width: 191mm, 
Weight:   1.160kg
ISBN:   9780128194041
ISBN 10:   0128194049
Pages:   566
Publication Date:  
Audience:   Professional and scholarly ,  Undergraduate
Format:   Paperback
Publisher's Status:   Active

Dr. James M. Ntambi is Professor of Biochemistry and the Steenbock Professor of Nutritional Sciences, at the University of Wisconsin-Madison, as well as Adjunct Professor of Biological Chemistry at Johns Hopkins University School of Medicine. The focus of Dr. Ntambi's research is to understand the genetic regulation of metabolism, adipocyte biology, and differentiation. He is specifically interested in the genetic basis of obesity, cardiovascular disease, insulin resistance, diabetes and fatty live disease and how dietary factors, hormones, and environmental factors influence these disease states. Most recently, his team have genetically engineered mice that are born without the stearoyl-CoA desaturase gene-1, and found that these mice resist obesity, diabetes, and fatty liver disease. Dr. Ntambi also conducts research on obesity and diabetes and other non-communicable metabolic diseases in developing countries. He has set up the Lweza-Mukono Community Health Initiatives Inc. (lwezahealth.org) a registered organization operating as a center of excellence in Lweza village Mukono District, Uganda implementing projects linking health to agriculture, nutrition and education to address, prevent, delay and manage the non-communicable metabolic diseases referred to above. Dr. Ntambi has published more than 200 scientific articles in such journals as Cell Metabolism, JBC, Journal of Lipid research, PNAS, JCI, Scientific Reports, PLoS ONE, BBRC, Gastroenterology, and Journal of Hepatology.

See Also